Related Experiment Video
Updated: Mar 25, 2026

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.3K
Persistent Atrial Fibrillation Ablation using the Tip-Versatile Ablation Catheter
Edward J Davies1, Ben Clayton1, Ian Lines1
1South West Cardiothoracic Centre, Plymouth, UK.
Heart, Lung & Circulation
|February 25, 2016
Summary
A new catheter ablation technique for persistent atrial fibrillation (PsAF) shows promise. The Tip-Versatile Ablation Catheter (T-VAC) achieved 60% arrhythmia-free survival in selected patients after over two years.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Mechanisms of persistent atrial fibrillation (PsAF) are not fully understood.
- Optimal ablative strategies for PsAF are debated due to complexity and time.
- Novel catheter ablation techniques are needed for PsAF management.
Purpose of the Study:
- To assess the efficacy of the Tip-Versatile Ablation Catheter (T-VAC) technique.
- To evaluate a novel, rapidly delivered empirical technique for PsAF ablation.
- To determine long-term outcomes of T-VAC in PsAF patients.
Main Methods:
- Prospective data collection from 40 patients (44 procedures) undergoing PsAF ablation with T-VAC.
- Primary endpoint: freedom from arrhythmia at >2-year follow-up.
- Secondary endpoints: time to recurrence, AF freedom on/off antiarrhythmic drugs (AAD), procedure/fluoroscopy time, complications.
Main Results:
- At 33 months mean follow-up, 45% de novo patients achieved freedom from arrhythmia recurrence.
- Overall, 60% of de novo patients maintained sustained normal sinus rhythm long-term.
- An additional 15% reported occasional AF paroxysms; procedure time averaged 192 minutes.
Conclusions:
- The T-VAC technique can achieve a 60% arrhythmia-free survival rate off AAD in selected PsAF patients.
- This novel technique offers a potentially effective approach to managing persistent atrial fibrillation.
- Long-term follow-up demonstrates sustained efficacy for the T-VAC method.

